
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cognitive outcomes associated with long-term, regular, recreational cannabis use in adults: A meta-analysis.
Monica E. Lovell, Jane Akhurst, Christine Padgett, et al.
Experimental and Clinical Psychopharmacology (2019) Vol. 28, Iss. 4, pp. 471-494
Closed Access | Times Cited: 72
Monica E. Lovell, Jane Akhurst, Christine Padgett, et al.
Experimental and Clinical Psychopharmacology (2019) Vol. 28, Iss. 4, pp. 471-494
Closed Access | Times Cited: 72
Showing 1-25 of 72 citing articles:
The C Factor: Cognitive dysfunction as a transdiagnostic dimension in psychopathology
Amitai Abramovitch, Tatiana Short, Avraham Schweiger
Clinical Psychology Review (2021) Vol. 86, pp. 102007-102007
Closed Access | Times Cited: 166
Amitai Abramovitch, Tatiana Short, Avraham Schweiger
Clinical Psychology Review (2021) Vol. 86, pp. 102007-102007
Closed Access | Times Cited: 166
Lower-Risk Cannabis Use Guidelines (LRCUG) for reducing health harms from non-medical cannabis use: A comprehensive evidence and recommendations update
Benedikt Fischer, Tessa Robinson, Chris Bullen, et al.
International Journal of Drug Policy (2021) Vol. 99, pp. 103381-103381
Open Access | Times Cited: 133
Benedikt Fischer, Tessa Robinson, Chris Bullen, et al.
International Journal of Drug Policy (2021) Vol. 99, pp. 103381-103381
Open Access | Times Cited: 133
Public health impacts to date of the legalisation of medical and recreational cannabis use in the USA
Vivian Chiu, Janni Leung, Wayne Hall, et al.
Neuropharmacology (2021) Vol. 193, pp. 108610-108610
Closed Access | Times Cited: 68
Vivian Chiu, Janni Leung, Wayne Hall, et al.
Neuropharmacology (2021) Vol. 193, pp. 108610-108610
Closed Access | Times Cited: 68
Evidence on the acute and residual neurocognitive effects of cannabis use in adolescents and adults: a systematic meta‐review of meta‐analyses
Laura Dellazizzo, Stéphane Potvin, Sabrina Giguère, et al.
Addiction (2022) Vol. 117, Iss. 7, pp. 1857-1870
Closed Access | Times Cited: 68
Laura Dellazizzo, Stéphane Potvin, Sabrina Giguère, et al.
Addiction (2022) Vol. 117, Iss. 7, pp. 1857-1870
Closed Access | Times Cited: 68
Long-Term Cannabis Use and Cognitive Reserves and Hippocampal Volume in Midlife
Madeline H. Meier, Avshalom Caspi, Annchen R. Knodt, et al.
American Journal of Psychiatry (2022) Vol. 179, Iss. 5, pp. 362-374
Open Access | Times Cited: 58
Madeline H. Meier, Avshalom Caspi, Annchen R. Knodt, et al.
American Journal of Psychiatry (2022) Vol. 179, Iss. 5, pp. 362-374
Open Access | Times Cited: 58
Recreational cannabis legalization alters associations among cannabis use, perception of risk, and cannabis use disorder treatment for adolescents and young adults
Jeremy Mennis, Thomas P. McKeon, Gerald J. Stahler
Addictive Behaviors (2022) Vol. 138, pp. 107552-107552
Closed Access | Times Cited: 57
Jeremy Mennis, Thomas P. McKeon, Gerald J. Stahler
Addictive Behaviors (2022) Vol. 138, pp. 107552-107552
Closed Access | Times Cited: 57
Negative affectivity drivers of impulsivity in opioid use disorder
Jasmin Vassileva, Elena Psederska, James M. Bjork
Nature Reviews Psychology (2025)
Closed Access | Times Cited: 1
Jasmin Vassileva, Elena Psederska, James M. Bjork
Nature Reviews Psychology (2025)
Closed Access | Times Cited: 1
Dopamine, endocannabinoids and their interaction in fear extinction and negative affect in PTSD
Luke J. Ney, Jane Akhurst, Raimondo Bruno, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2020) Vol. 105, pp. 110118-110118
Closed Access | Times Cited: 52
Luke J. Ney, Jane Akhurst, Raimondo Bruno, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2020) Vol. 105, pp. 110118-110118
Closed Access | Times Cited: 52
Use of Marijuana: Effect on Brain Health: A Scientific Statement From the American Heart Association
Fernando D. Testai, Philip B. Gorelick, Hugo J. Aparicio, et al.
Stroke (2022) Vol. 53, Iss. 4
Open Access | Times Cited: 32
Fernando D. Testai, Philip B. Gorelick, Hugo J. Aparicio, et al.
Stroke (2022) Vol. 53, Iss. 4
Open Access | Times Cited: 32
Unraveling the Intoxicating and Therapeutic Effects of Cannabis Ingredients on Psychosis and Cognition
Marco Colizzi, Mirella Ruggeri, Sagnik Bhattacharyya
Frontiers in Psychology (2020) Vol. 11
Open Access | Times Cited: 49
Marco Colizzi, Mirella Ruggeri, Sagnik Bhattacharyya
Frontiers in Psychology (2020) Vol. 11
Open Access | Times Cited: 49
Cannabis and Cognitive Functioning: From Acute to Residual Effects, From Randomized Controlled Trials to Prospective Designs
Josiane Bourque, Stéphane Potvin
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 40
Josiane Bourque, Stéphane Potvin
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 40
Reducing medical cannabis use risk among Veterans: A descriptive study
Laura M. Harris-Lane, M Sheehy, Courtney Loveless, et al.
Harm Reduction Journal (2025) Vol. 22, Iss. 1
Open Access
Laura M. Harris-Lane, M Sheehy, Courtney Loveless, et al.
Harm Reduction Journal (2025) Vol. 22, Iss. 1
Open Access
Altered Functional Connectivity Dynamics Serving Cognitive Flexibility in Regular Cannabis Users
Kellen M. McDonald, Mikki Schantell, Jason A. John, et al.
Addiction Biology (2025) Vol. 30, Iss. 3
Open Access
Kellen M. McDonald, Mikki Schantell, Jason A. John, et al.
Addiction Biology (2025) Vol. 30, Iss. 3
Open Access
Acute effects of partial CB1 receptor agonists on cognition – A meta-analysis of human studies
Simon Zhornitsky, Julie Pelletier, Roxane Assaf, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2020) Vol. 104, pp. 110063-110063
Closed Access | Times Cited: 34
Simon Zhornitsky, Julie Pelletier, Roxane Assaf, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2020) Vol. 104, pp. 110063-110063
Closed Access | Times Cited: 34
Cannabis and driving ability
Eric L. Sevigny
Current Opinion in Psychology (2021) Vol. 38, pp. 75-79
Open Access | Times Cited: 30
Eric L. Sevigny
Current Opinion in Psychology (2021) Vol. 38, pp. 75-79
Open Access | Times Cited: 30
Effect of four-week cannabidiol treatment on cognitive function: secondary outcomes from a randomised clinical trial for the treatment of cannabis use disorder
Rachel Lees, Lindsey A. Hines, Chandni Hindocha, et al.
Psychopharmacology (2023) Vol. 240, Iss. 2, pp. 337-346
Open Access | Times Cited: 11
Rachel Lees, Lindsey A. Hines, Chandni Hindocha, et al.
Psychopharmacology (2023) Vol. 240, Iss. 2, pp. 337-346
Open Access | Times Cited: 11
The neural oscillations serving task switching are altered in cannabis users
Kellen M. McDonald, Mikki Schantell, Lucy K Horne, et al.
Journal of Psychopharmacology (2024) Vol. 38, Iss. 5, pp. 471-480
Closed Access | Times Cited: 4
Kellen M. McDonald, Mikki Schantell, Lucy K Horne, et al.
Journal of Psychopharmacology (2024) Vol. 38, Iss. 5, pp. 471-480
Closed Access | Times Cited: 4
Conceptualization and characterization of “primary” and “secondary” cognitive impairment in schizophrenia
Antonio Vita, Gabriele Nibbio, Sergio Barlati
Psychiatry Research (2024) Vol. 340, pp. 116126-116126
Open Access | Times Cited: 4
Antonio Vita, Gabriele Nibbio, Sergio Barlati
Psychiatry Research (2024) Vol. 340, pp. 116126-116126
Open Access | Times Cited: 4
Central Nervous System: Sleep, Cognition and Neuroprotection
Jean-Paul Henri Dedam, Matthew Fogel, Elizabeth Fogel
(2025), pp. 97-107
Closed Access
Jean-Paul Henri Dedam, Matthew Fogel, Elizabeth Fogel
(2025), pp. 97-107
Closed Access
Cannabis Use and Cognitive Functioning Across the Lifespan
Madeline H. Meier, M. Foster Olive, Olivia A. Jenks, et al.
Current Addiction Reports (2024) Vol. 11, Iss. 3, pp. 384-395
Closed Access | Times Cited: 3
Madeline H. Meier, M. Foster Olive, Olivia A. Jenks, et al.
Current Addiction Reports (2024) Vol. 11, Iss. 3, pp. 384-395
Closed Access | Times Cited: 3
Definition, assessment and treatment of cognitive impairment associated with schizophrenia: expert opinion and practical recommendations
Antonio Vita, Sergio Barlati, Roberto Cavallaro, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 3
Antonio Vita, Sergio Barlati, Roberto Cavallaro, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 3
Effects of daily Δ9-Tetrahydrocannabinol (THC) alone or combined with cannabidiol (CBD) on cognition-based behavior and activity in adolescent nonhuman primates
Sarah L. Withey, Brian D. Kangas, Sophia Charles, et al.
Drug and Alcohol Dependence (2021) Vol. 221, pp. 108629-108629
Open Access | Times Cited: 20
Sarah L. Withey, Brian D. Kangas, Sophia Charles, et al.
Drug and Alcohol Dependence (2021) Vol. 221, pp. 108629-108629
Open Access | Times Cited: 20
Neuroplasticity, the Prefrontal Cortex, and Psychopathology-Related Deviations in Cognitive Control
Mónica Luciana, Paul F. Collins
Annual Review of Clinical Psychology (2022) Vol. 18, Iss. 1, pp. 443-469
Closed Access | Times Cited: 13
Mónica Luciana, Paul F. Collins
Annual Review of Clinical Psychology (2022) Vol. 18, Iss. 1, pp. 443-469
Closed Access | Times Cited: 13
Regular cannabis use modulates the impact of HIV on the neural dynamics serving cognitive control
Mikki Schantell, Seth D. Springer, Yasra Arif, et al.
Journal of Psychopharmacology (2022) Vol. 36, Iss. 12, pp. 1324-1337
Open Access | Times Cited: 13
Mikki Schantell, Seth D. Springer, Yasra Arif, et al.
Journal of Psychopharmacology (2022) Vol. 36, Iss. 12, pp. 1324-1337
Open Access | Times Cited: 13
Attention-deficit/hyperactivity disorder (ADHD) symptoms and their relation to diagnosed ADHD, sociodemographic characteristics, and substance use among patients receiving opioid agonist therapy: a Norwegian cohort study
Jørn Henrik Vold, Anne Halmøy, Fatemeh Chalabianloo, et al.
BMC Psychiatry (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 7
Jørn Henrik Vold, Anne Halmøy, Fatemeh Chalabianloo, et al.
BMC Psychiatry (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 7